Maryland HB1380 mandates health insurance coverage for gender-affirming care and hormone therapy prescriptions, and regulates dispensing limits.
Maryland HB1380 requires health insurance policies and contracts to cover a 12-month supply of qualifying prescriptions for gender-affirming care and hormone therapy. It allows temporary limits to a 90-day supply during acute shortages and restricts dispensing if a 12-month supply was already provided in the last quarter of the plan year. The bill also mandates that insurers cannot require enrollees to accept a 12-month supply if they request a smaller amount or if the prescriber indicates specific levels.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.